FibroGen
FGEN
FGEN
187 hedge funds and large institutions have $3.39B invested in FibroGen in 2018 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 52 increasing their positions, 73 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
16% less capital invested
Capital invested by funds: $4.05B → $3.39B (-$654M)
21% less call options, than puts
Call options by funds: $32.9M | Put options by funds: $41.4M
29% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 73
Holders
187
Holding in Top 10
4
Calls
$32.9M
Puts
$41.4M
Top Buyers
| 1 | +$27.5M | |
| 2 | +$13.5M | |
| 3 | +$9.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$8.36M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.6M |
Top Sellers
| 1 | -$479M | |
| 2 | -$50.7M | |
| 3 | -$19.6M | |
| 4 |
Goldman Sachs
New York
|
-$14.3M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$12.5M |